Back to today’s briefing

Story perspectives

Survivor of Leukemia Faces New Battle with Breast Cancer

7/28/2025

50 4

Summary

Danika Hilmer's Triumph

After battling acute myeloid leukemia following childbirth, 34-year-old Danika Hilmer from Marion, Iowa, triumphed over her illness with chemotherapy and a successful stem cell transplant. Now in remission, she faces a new challenge with breast cancer. Hilmer passionately urges others to prioritize regular health check-ups to detect issues early and safeguard their health.

Summary

QL1706's Breakthrough Impact

A groundbreaking study on QL1706, a dual-action anti-PD-1/CTLA-4 antibody, reveals its potential to provide lasting benefits for patients battling EGFR-mutant non-small cell lung cancer (NSCLC) after traditional treatments fail. When paired with chemotherapy and bevacizumab, patients experienced enhanced progression-free survival, paving the way for future trials to validate these encouraging results.

1 of 2

Danika Hilmer's Triumph

After battling acute myeloid leukemia following childbirth, 34-year-old Danika Hilmer from Marion, Iowa, triumphed over her illness with chemotherapy and a successful stem cell transplant. Now in remission, she faces a new challenge with breast cancer. Hilmer passionately urges others to prioritize regular health check-ups to detect issues early and safeguard their health.

1 / 2